The estimated Net Worth of Ronald D Mc Call is at least $4.17 million dollars as of 25 August 2021. Mr. Call owns over 5,667 units of Artivion Inc stock worth over $2,177,212 and over the last 21 years he sold CRY stock worth over $1,795,836. In addition, he makes $195,015 as Presiding Independent Director at Artivion Inc.
Ronald has made over 28 trades of the Artivion Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 5,667 units of CRY stock worth $145,245 on 25 August 2021.
The largest trade he's ever made was exercising 20,800 units of Artivion Inc stock on 3 April 2007 worth over $64,896. On average, Ronald trades about 2,603 units every 104 days since 2003. As of 25 August 2021 he still owns at least 121,768 units of Artivion Inc stock.
You can see the complete history of Mr. Call stock trades at the bottom of the page.
Ronald D. McCall Esq. serves as Presiding Independent Director of the Company., is an Independent Director of CryoLife, Inc., Mr. McCall has served as a director of CryoLife since January 1984. From 1985 to the present, Mr. McCall has been the owner of the law firm Ronald D. McCall, P.A., based in Tampa, Florida. Mr. McCall was admitted to the practice of law in Florida in 1961. Mr. McCall received a B.A. and a J.D. from the University of Florida.
As the Presiding Independent Director of Artivion Inc, the total compensation of Ronald McCall at Artivion Inc is $195,015. There are 10 executives at Artivion Inc getting paid more, with James Mackin having the highest compensation of $6,453,540.
Ronald McCall is 83, he's been the Presiding Independent Director of Artivion Inc since 2005. There are no older and 23 younger executives at Artivion Inc.
Ronald's mailing address filed with the SEC is CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW, GA, 30144.
Over the last 21 years, insiders at Artivion Inc have traded over $18,346,910 worth of Artivion Inc stock and bought 91,700 units worth $1,086,548 . The most active insiders traders include Steven G Anderson, Thomas F Ackerman et James P Mackin. On average, Artivion Inc executives and independent directors trade stock every 26 days with the average trade being worth of $211,842. The most recent stock trade was executed by Amy Horton on 8 December 2021, trading 2,500 units of CRY stock currently worth $46,425.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
Artivion Inc executives and other stock owners filed with the SEC include: